New Phase
PrivateLast Round
Seed
Oct 22, 2025
Total Funding Raised
$35M
Company Overview
New Phase operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Seed round in October 2025.
New Phase is a biotechnology company that has developed a therapeutic technology based on nanoparticles designed to treat metastatic solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Government Contracts, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
New Phase Comparables
Compare New Phase with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanotherm Therapeutics, Inc. | 84% | |
| MagHeals | 81% | |
| Sona Nanotech | 81% |
For institutional investors. Book with your work email.
New Phase Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 22, 2025 | ||||
| Grant | Jan 19, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
New Phase Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BIRD Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 36% MoM.
- Jan 5, 2026
Monthly visitors increased 48% MoM.
For institutional investors. Book with your work email.
New Phase Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about New Phase's valuation, stock price, and market status.
Is New Phase a public or private company?
New Phase is a private company.
What is the current stock price of New Phase?
New Phase is a private company, so its shares have no public market price. Caplight tracks New Phase's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is New Phase worth (valuation)?
Valuation information for New Phase is not publicly available.
Can I buy New Phase stock?
New Phase shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was New Phase's last funding round?
New Phase's most recent funding round was Seed on October 22, 2025.
Who are the main investors in New Phase?
Key investors in New Phase include BIRD Foundation.
Will New Phase IPO soon?
No public IPO plans have been announced for New Phase.
How can I track New Phase secondary market activity?
Caplight tracks bids, offers, and trades in New Phase's shares on secondary markets.